Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot
2021-01-01 Parigi, Tommaso Lorenzo; D'Amico, Ferdinando; Danese, Silvio
Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
2017-01-01 Rosario, M; French, Jl; Dirks, Nl; Sankoh, S; Parikh, A; Yang, Hy; Danese, S; Colombel, Jf; Smyth, M; Sandborn, Wj; Feagan, Bg; Reinisch, W; Sands, Be; Sans, M; Fox, I
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY
2011-01-01 Repici, A; Moro, L; Loprete, L; Hassan, C; Danese, S
Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events
2003-01-01 Papa, A; Danese, S; Piccirillo, N; Toriani-Terenzil, C; Bartolozzi, F; Piscaglia, Ac; Grillo, A; Leone, G; Gentiloni-Silveri, N; Gasbarrini, G; Gasbarrini, A
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease
2007-01-01 Danese, S; Scaldaferri, F; Vetrano, S; Stefanelli, T; Graziani, C; Repici, A; Ricci, R; Straface, G; Sgambato, A; Malesci, A; Fiocchi, C; Rutella, S
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply
2018-01-01 Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Microscopic features of colorectal neoplasia in inflammatory bowel diseases
2014-01-01 Bressenot, A; Cahn, V; Danese, S; Peyrin-Biroulet, L
Association between Helicobacter pylori cytotoxic type I strains and migraine with aura
1999-01-01 Gabrielli, M; Gasbarrini, A; Candelli, M; Franceschi, F; Fiore, G; Ojetti, V; Armuzzi, A; Danese, S; Carloni, E; Giacovazzo, M; Pola, P; Gasbarrini, G
Ustekinumab in the management of Crohn's disease: Expert opinion
2018-01-01 Armuzzi, A; Ardizzone, S; Biancone, L; Castiglione, F; Danese, S; Gionchetti, P; Orlando, A; Rizzello, F; Scribano, Ml; Vecchi, M; Daperno, M
New Mechanisms and Targets for IBD Therapy: Translational Gastroenterology Comes of Age
2013-01-01 Danese, S; Peyrin-Biroulet, L
Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach!
2018-01-01 Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L
Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation
2021-01-01 Allocca, Mariangela; Filippi, Elisabetta; Costantino, Andrea; Bonovas, Stefanos; Fiorino, Gionata; Furfaro, Federica; Peyrin-Biroulet, Laurent; Fraquelli, Mirella; Caprioli, Flavio; Danese, Silvio
Long-term safety of approved biologics for ulcerative colitis
2020-01-01 D'Amico, Ferdinando; Parigi, Tommaso Lorenzo; Bonovas, Stefanos; Peyrin-Biroulet, Laurent; Danese, Silvio
Inflammatory bowel disease: estimates from the global burden of disease 2017 study
2020-01-01 Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S
Management of IBD during the COVID-19 outbreak: resetting clinical priorities
2020-01-01 Danese, Silvio; Cecconi, Maurizio; Spinelli, Antonino
Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease
2009-01-01 Fiorino, G.; Allez, M.; Malesci, A.; Danese, S.
Cross-Sectional Imaging Modalities in Crohn's Disease
2013-01-01 Allocca, M; Fiorino, G; Danese, S
Bowel Damage Assessment in Crohn's Disease by Magnetic Resonance Imaging
2012-01-01 Fiorino, G; Peyrin-Biroulet, L; Danese, S
Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies
2010-01-01 Bonanno, G; Procoli, A; Mariotti, A; Corallo, M; Perillo, A; Danese, S; De Cristofaro, R; Scambia, G; Rutella, S
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
1994-01-01 Delturco, Mr; Palli, D; Cariddi, A; Ciatto, S; Pacini, P; Distante, V; Azzini, V; Belsanti, V; Bartolucci, R; Dicostanzo, F; Bertusi, M; Danese, S; Giardina, G; Daiuto, G; Uccello, V; Deleo, G; Punzo, C; Gosso, P; Griso, C; Locatelli, E; Mansutti, M; Sandri, P; Molino, Am; Schincaglia, P; Tienghi, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot | 1-gen-2021 | Parigi, Tommaso Lorenzo; D'Amico, Ferdinando; Danese, Silvio | |
| Exposure-efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease | 1-gen-2017 | Rosario, M; French, Jl; Dirks, Nl; Sankoh, S; Parikh, A; Yang, Hy; Danese, S; Colombel, Jf; Smyth, M; Sandborn, Wj; Feagan, Bg; Reinisch, W; Sands, Be; Sans, M; Fox, I | |
| A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY | 1-gen-2011 | Repici, A; Moro, L; Loprete, L; Hassan, C; Danese, S | |
| Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events | 1-gen-2003 | Papa, A; Danese, S; Piccirillo, N; Toriani-Terenzil, C; Bartolozzi, F; Piscaglia, Ac; Grillo, A; Leone, G; Gentiloni-Silveri, N; Gasbarrini, G; Gasbarrini, A | |
| Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease | 1-gen-2007 | Danese, S; Scaldaferri, F; Vetrano, S; Stefanelli, T; Graziani, C; Repici, A; Ricci, R; Straface, G; Sgambato, A; Malesci, A; Fiocchi, C; Rutella, S | |
| Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply | 1-gen-2018 | Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S | |
| Microscopic features of colorectal neoplasia in inflammatory bowel diseases | 1-gen-2014 | Bressenot, A; Cahn, V; Danese, S; Peyrin-Biroulet, L | |
| Association between Helicobacter pylori cytotoxic type I strains and migraine with aura | 1-gen-1999 | Gabrielli, M; Gasbarrini, A; Candelli, M; Franceschi, F; Fiore, G; Ojetti, V; Armuzzi, A; Danese, S; Carloni, E; Giacovazzo, M; Pola, P; Gasbarrini, G | |
| Ustekinumab in the management of Crohn's disease: Expert opinion | 1-gen-2018 | Armuzzi, A; Ardizzone, S; Biancone, L; Castiglione, F; Danese, S; Gionchetti, P; Orlando, A; Rizzello, F; Scribano, Ml; Vecchi, M; Daperno, M | |
| New Mechanisms and Targets for IBD Therapy: Translational Gastroenterology Comes of Age | 1-gen-2013 | Danese, S; Peyrin-Biroulet, L | |
| Telehealth in Inflammatory Bowel Disease: Every Patient May Need a Coach! | 1-gen-2018 | Jaboli, F; Pouillon, L; Bossuyt, P; Danese, S; Peyrin-Biroulet, L | |
| Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation | 1-gen-2021 | Allocca, Mariangela; Filippi, Elisabetta; Costantino, Andrea; Bonovas, Stefanos; Fiorino, Gionata; Furfaro, Federica; Peyrin-Biroulet, Laurent; Fraquelli, Mirella; Caprioli, Flavio; Danese, Silvio | |
| Long-term safety of approved biologics for ulcerative colitis | 1-gen-2020 | D'Amico, Ferdinando; Parigi, Tommaso Lorenzo; Bonovas, Stefanos; Peyrin-Biroulet, Laurent; Danese, Silvio | |
| Inflammatory bowel disease: estimates from the global burden of disease 2017 study | 1-gen-2020 | Piovani, D; Danese, S; Peyrin-Biroulet, L; Bonovas, S | |
| Management of IBD during the COVID-19 outbreak: resetting clinical priorities | 1-gen-2020 | Danese, Silvio; Cecconi, Maurizio; Spinelli, Antonino | |
| Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease | 1-gen-2009 | Fiorino, G.; Allez, M.; Malesci, A.; Danese, S. | |
| Cross-Sectional Imaging Modalities in Crohn's Disease | 1-gen-2013 | Allocca, M; Fiorino, G; Danese, S | |
| Bowel Damage Assessment in Crohn's Disease by Magnetic Resonance Imaging | 1-gen-2012 | Fiorino, G; Peyrin-Biroulet, L; Danese, S | |
| Effects of pegylated G-CSF on immune cell number and function in patients with gynecological malignancies | 1-gen-2010 | Bonanno, G; Procoli, A; Mariotti, A; Corallo, M; Perillo, A; Danese, S; De Cristofaro, R; Scambia, G; Rutella, S | |
| INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL | 1-gen-1994 | Delturco, Mr; Palli, D; Cariddi, A; Ciatto, S; Pacini, P; Distante, V; Azzini, V; Belsanti, V; Bartolucci, R; Dicostanzo, F; Bertusi, M; Danese, S; Giardina, G; Daiuto, G; Uccello, V; Deleo, G; Punzo, C; Gosso, P; Griso, C; Locatelli, E; Mansutti, M; Sandri, P; Molino, Am; Schincaglia, P; Tienghi, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1